• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

M&A: Florence Acquires Virtual Care Solution Zipnosis

by Syed Hamza Sohail 05/24/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

  • Florence,  an innovator in healthcare enablement software, announced today its acquisition of Zipnosis, an asynchronous-first virtual care solution that creates efficiency for clinicians while making quality care more accessible and affordable for patients. 
  • Through this acquisition, Florence will broaden its product offerings with synchronous and asynchronous virtual care and further their mission to create a consumer-centric interface that engages patients at every stage of their journey across virtual and physical care to solve healthcare’s most significant constraint: clinical capacity. 

Solving Clinical Capacity Constraints and Creating Omnichannel Transformation Across Telehealth and Hybrid Care

“Zipnosis’ asynchronous telemedicine solution is the best in the industry and perfectly aligns with Florence’s vision to create capacity to care in physical settings,” said Aniq Rahman, CEO of Florence. “Together, we’ll create exceptional healthcare experiences for patients virtually and in-clinic while freeing up time for clinicians to focus on what they do best, care for patients.”

Adding to Florence’s already robust platform, Zipnosis boosts patient accessibility and frees up 99% of provider work time by using intelligent adaptive interviews that enable care delivery in just 89 seconds. As a result, physicians are able to treat more patients while allocating additional time to those with greater needs. Zipnosis has facilitated 4.5 million patient encounters and engaged 3,500 physicians at over 50 different top health institutions.

The acquisition follows Florence’s formal launch last month, at which time the company announced $20 million in seed funding led by Thrive Capital, GV (Google Ventures), and Salesforce Ventures. With Florence, patients benefit from an experience that rivals consumer-focused industries with the ability to track and accelerate their healthcare journey via smartphone, update clinical information, facilitate prescription fulfillment, initiate self-discharge and schedule follow-up appointments. Florence is dedicated to developing products across multiple sites of care to boost patient satisfaction, increase clinical capacity and reduce rates of patients leaving without being seen by enabling health systems to create omnichannel transformation across telehealth and hybrid care in sites like the emergency room and beyond.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Healthcare Mergers & Acquisitions, Virtual Care

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |